Schreiber Alain
SEC-identified person · CIK 1225149 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Urogen Pharma Ltd. URGN | Officer | filed 2017 - 2017 |
| Eagle Pharmaceuticals, INC. EGRX | Director | filed 2014 - 2017 |
| Agile Therapeutics INC AGRX | Officer | filed 2014 - 2016 |
| Immune Design Corp. IMDZ | Officer | filed 2014 - 2015 |
| Novadel Pharma INC nvd | Officer | filed 2006 - 2012 |
| Optimer Pharmaceuticals INC OPTR | Director | filed 2007 - 2010 |
| Achillion Pharmaceuticals INC ACHN | Officer | filed 2008 - 2009 |
| Avanir Pharmaceuticals, INC. AVNR | Officer | filed 2008 - 2009 |
| Cadence Pharmaceuticals INC CADX | Director | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.